New Research: Cracking The Targeted Drug Resistance Puzzle And Eliminating Cancer Cells Before They Evolve!

Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer!

Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!

Speaking of medical history should focus on the key points

New Research Shows Promise For Bone Marrow Transplant Recipient Patients To Reduce Treatment Side Effects!

MD Anderson Cancer Center, USA